Thursday, February 9, 2012

Biotech drugs cost

  • WASHINGTON -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications that have never before faced generic competition in the U.S.
  • (Huffington Post)
  • (Reuters) - The U.S. Food and Drug Administration issued its long-awaited guidelines for the sale of lower-cost versions of brand-name biotechnology drugs. The proposed rules apply to multi-billion-dollar products such as Amgen Incs Epogen anemia drug.
  • (Reuters India)
  • WASHINGTON — The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications that have never before faced generic competition in the U.S.
  • (Washington Post)
  • has underlined the popularity of contract manufacturing as it has become synonymous with cost-cutting and the timely entry of products into the market.
  • (Yahoo Finance)
  • licensed the drug to Cougar Biotechnology Inc., which was acquired by JJ in 2009. NICE's decisions apply to the NHS in England and Wales. The Scottish Medicines Consortium advises the NHS in Scotland on the cost-effectiveness of drugs.
  • (Businessweek)
  • Biotech giant Amgen, fresh off mixed earnings, said it will shell out $1.16 billion to broaden its product pipeline by buying fellow drug developer Micromet Inc over year — largely because of higher costs — to about $3.7 billion, or $4.
  • (Los Angeles Times)
  • While low-cost copies of biotech drugs are used in Europe, none has yet been approved in the U.S.
  • (Bloomberg)
  • The program would cost drug companies about 1 cent for every $16 in sales which represents the country's top pharmaceutical research and biotechnology companies, is among the advocates opposing the state legislation.
  • (Columbian)
  • Today, it takes 15 years to get a drug approved. A global launch costs $2 billion -- up from $150 million 20 years ago. How to Play the Biotech Investment Game There are two ways you can engage in this sector.
  • (MSN Money)

No comments:

Post a Comment

Post a Comment